Bolak Co (002760.KS) Stock Price

Bolak Co Price

CLOSED
925.00
​
Market closed

Revenue has compounded at 6.6% per year over the past 19 years to 50.12 B KRW. Earnings per share have grown at 4.9% per year over the last 19 years. Bolak Co's net margin stands at 4.7%, broadly stable from 4.3% several years earlier. Bolak Co currently offers a dividend yield of about 0.54%. The payout ratio is around 22% of earnings.

Bolak Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bolak Co business model & stock analysis

Bolak Co., Ltd. generates revenue through its two core business divisions: food additives and pharmaceutical ingredients. The food additives division produces flavors, colors, botanical extracts, nutraceuticals, white emulsion, antioxidants, emulsifiers, bleaching agents, acidulant, and sweetness products. The pharmaceutical ingredients division manufactures extract powers, fluid extracts, tinctures, protein concentrates, and calcium carboxymethyl cellulose (CMC). Domestic and overseas markets purchase these products, with the company distributing them across both regions. The firm's product portfolio targets food manufacturers and pharmaceutical companies seeking raw materials for their production processes. Bolak Co., Ltd. serves food manufacturers and pharmaceutical companies as its primary customer segments. These segments require specialized ingredients for their product development and production lines. The company's domestic market includes Korean food and pharma firms, while overseas buyers include international food processors and pharmaceutical producers. The firm's product range supports both the food and pharmaceutical industries through direct sales to these end-users. The company's revenue streams are derived from the sale of its manufactured ingredients, with no mention of additional services or licensing. Food additives like white emulsion and antioxidants are sold to food producers, while pharmaceutical ingredients such as protein concentrates and CMC are supplied to drug manufacturers. The business model relies on consistent demand for these raw materials from established industry clients.

Frequently asked questions about Bolak Co

Converted at the current exchange rate, the Bolak Co share trades at 0.62 EUR (925.00 KRW).

The revenue cannot currently be calculated for Bolak Co.

The profit cannot currently be calculated for Bolak Co.

The P/E ratio cannot be calculated for Bolak Co at the moment.

The P/S cannot be calculated for Bolak Co currently.

The Eulerpool Quality Score for Bolak Co is 2/10.

The ISIN of Bolak Co is KR7002760007. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Bolak Co is 002760.KS. The ticker symbol is used to trade Bolak Co shares on the stock exchange.

Fair ValueTerminal
962.00 KRW
Over-/UndervaluationTerminal
Fairly valued
Industry
Chemicals
Number of shares
Employees
Revenue per Employee
365.81 M KRW
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website bolak.co.kr
Country
South Korea
Currency
KRW
Initial public offering
Nov 30, 1989
ISIN
KR7002760007
Cusip
Y09205108
Market capitalization
55.41 B KRWLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
21.29
P/B Ratio
1.14
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
4.80 %
Dividend
Dividend yield
0.54 %
Payout Ratio
22.08 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
0 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
22.00 %
Last updated Oct 24, 2026, 6:17 AM

Bolak Co Peer Group

Bolak Co FIGI

002760:KS · BBG000BGZ137002760:KP · BBG000BGZ217

All fundamentals and in-depth analysis of Bolak Co

Our stock analysis for Bolak Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bolak Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.